干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 41408|回复: 0
go

干细胞移植常用生物学词汇 [复制链接]

Rank: 1

积分
威望
3  
包包
20  
楼主
发表于 2008-12-27 14:20 |显示全部帖子 |倒序浏览 |打印
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸9 @8 d) i* b& q1 U) i
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
1 x" P# B$ B2 d$ J6 r. g3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷- Q/ D4 Z& _4 X! V
5-Aza:5-azacytidine,5-氮(杂)胞苷. G/ U: k0 `! ?
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
2 G% q; x& i0 d6 k0 q7 ?5 y: {AA:aplastic anemia,再生障碍性贫血
+ `- e+ J% |' k8 t2 NAAV:adeno-associated virus,腺病毒相关病毒# G) W! M8 J) A9 H( n9 a+ |
Ab:antibody,抗体
9 G4 {+ U& l7 u9 \2 UABC:avidin-biiotin complex method, 亲和素生物素复合物法
! i0 ~  i1 z/ uABMT:autologous bone marrow transplant,自体骨髓移植; |3 p: p' G+ B3 B2 X
Ac:accessory cell,辅佐细胞
% f: {2 _$ j4 A+ }1 yACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖/ x8 y0 _. i' A  ^
ACP:acid phosphatase,酸性磷酸梅
" t0 O3 J' w: T- Z3 Z0 DACTD:actinomycin D,放线菌素D
3 }( z- B. {+ P, WAcute:急性的
: v4 N. M& `, G# _2 Z$ W5 n! ]ACV:cyclovir,阿昔洛韦
3 Z/ p1 r& x' b, _Ad:adenovirus,腺病毒
$ t9 @2 Z! q3 p* OAD:antigen determinant,抗原决定簇
- m1 J$ s( M, A, m: vADA:adenosine deaminase,腺苷脱氨酶
+ ~; ?- L+ c! z4 x) @  A7 r- QADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性! a( X5 Z% g) N: m3 S5 L
Adjuvant therapy:辅助治疗- }. {! `* f6 O9 B+ e0 g3 J
AEL:acute erythrocytic leukemia,急性红白血病2 }6 c9 G) d6 M+ z* G3 Y- [
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病% O8 m3 l# B( ]( t6 ?1 l
AFP:alpha fetoprotein,甲胎蛋白
2 b8 S- d% W3 z8 R8 v$ y( uAg:antigen,抗原5 u4 O' q6 y7 C! T; ?1 C* o
aGVHD:acute graft versus host disease,急性移植物抗宿主病
/ {. F2 X" ?7 Q* B% A: s$ I; DAid:anti-idiotype antibody,抗独特型抗体, b6 r) Q7 x5 y% M  C" S
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
( p7 ~; L# j; P$ @& h6 y" UAIF:apoptosis-inducing factor,凋亡诱导因子
  L3 [: C2 c% b* F( ~AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
% D# b# I" A" n6 {( w9 jAL:acute leukemia, 急性白血病
/ [' K2 ~2 x# p0 }  \ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
" E' `" c6 M' v, L- U5 `; c; mALG:antilymphocyte globulin, 抗淋巴细胞球蛋白: ~7 \- i, g% s$ L/ I
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
* g0 e% Z8 p/ a5 f* N7 `ALL:acute lymphocytic leukemia,急性淋巴细胞白血病
" ?2 ~3 y. S9 L8 K# |  D$ TAllo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植0 x6 j6 l3 |% i: |
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
) E$ v4 I% t! {6 LAllogeneic:异基因的 , Y0 J/ ?8 E4 i/ {
Allograft:异体移植物 ( ^  ^- ]0 a, x3 y
Alopecia:脱发
9 h6 z; S$ {2 d3 e. `$ NALP(AKP):Alkaline phosphatase,碱性磷酸酶
$ e& e5 t% i, x, WAM:adhesion molecule,粘附分子* d! E$ d1 K, y" f+ a$ e
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
8 F, v0 G2 _2 D& x0 U# O& [0 s3 KAML:acute myeloid leukemia,急性髓性白血病
- P+ J0 c2 @% c- n7 U; MAMM:agnogenic myeloid metaplasia,特发性髓外化生2 _' H0 \/ p  b0 l
ANA:antinuclear antibody,抗核抗体 * H+ S; t% ^2 U% l
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤& H( i0 k4 ~2 g
Anaphylaxis:过敏症6 }5 u  F  v1 k, V0 e( g

5 f7 }$ Z9 K7 R6 x1 qANC:absolute neutrophil count,中性粒细胞绝对值+ ^2 C1 C) M1 J& p" s8 Q
Anemia:贫血/ i+ d, ?' i1 Z: m) D
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
* q# ?& W5 `, M' cAntibiotic:抗生素;抗生的 . {! W  [1 J/ a. \
Antiemetic:止吐剂,止吐药 , r. W' ?( D, B& q2 {6 q
antineoplastic drugs:抗肿瘤药物
5 P& R& S. H/ {  l: l9 d% p' _Antisense:反义引物
% \4 v6 |& Y  O) ?6 K6 E- j) FAPBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
  \5 U+ C# T3 A: wAPC:antigen processing cell,抗原呈递细胞
  J  d4 S" j. u* gApheresis:血浆分离置换法,血液成分部分清除
; i. X7 }; c5 q) P% s0 q# U. eAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病& }9 \1 `% K2 ^. P/ J2 L1 u. x
Aplasia:发育不良,成形不完全
. r* s  b# |& M( Q8 {* S7 a) X$ PApoptosis:凋亡
$ W6 g6 `$ L8 _7 OAra-C:arabinosyl cytosine,aracytidine阿糖胞苷) C7 G/ v+ m6 y/ D- }
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
0 H: E% X9 S* y/ {5 g$ GAscites:腹水 ; o2 e$ h" x8 Q5 b
ASCT:autologous stem cell transplantation,自体干细胞移植
7 ?, w, {6 H9 z! B- U8 ^' uAspergillus:曲霉属- N- q8 v, I; b) \) r
ASS:anterior superior spine,髂前上棘) ]6 [& H# c$ f1 J# n3 s; N3 a
AT1257:nitrocaphane,消瘤芥  z/ Z% P6 U& d1 z3 T0 u* ^# x! _
ATG:antithymocyte globulin,抗胸腺细胞球蛋白( w4 P& X' `0 ~
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
, d- _# {" `+ d' a. w" {ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
7 [! |& K( E5 y8 M* ]ATRA:all-transretinoic acid,全反式维甲酸. S2 U2 E+ f1 [7 x" B+ s) l
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病
4 ]; \9 B5 p/ `# B; VAuSCT: autologous stem cell transplantation,自体造血干细胞移植
4 K2 Z/ Q6 Y3 l8 g. ]4 ?4 {7 fAutologous:自体的
" O2 V+ o# h3 w2 _) L3 m+ e5 }; pAutograft:自体移植物 & _; f* Y+ I9 G$ G' ~% N/ _
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植5 y  \1 T' {. r1 [8 {
β2-MG:β2-microglobulin,β2-微球蛋白% H* w5 ~  A+ \9 Z& o" l
Back-up:备份
* h0 E* x! ]3 X2 A8 v1 w& D; bBCNU:Carmustine,卡氮芥,卡莫司汀
* A0 K$ {2 Y' L; ]' z  }6 cBCR:breakpoint cluster region,断裂点丛集区* D* t( n+ S3 \1 c$ K
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
6 h) a, r# j# W( h8 F9 Z6 ^; V, gBiopsy:活检
, V4 Y+ A* J/ I/ q- E) U1 g9 c% UBlast cell:原始血细胞,母细胞 9 ~# d9 @. C' k) q( Z) j
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞
2 t! g# ~- Q* i' fBlast crisis:原始细胞危象
# Q- Z  N1 d! |$ z- |Bm:memory B lymphocyte,记忆B淋巴细胞. U% ^6 {( b. D0 y0 i, h4 W0 D
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病- Y1 Q$ W! f: t% s! Z& G$ t: e
BMT:bone marrow transplantation,骨髓移植
. r  R, a- ~8 q% s! M& p; LBone marrow biopsy:骨髓活检, }: M1 H* _) |( w. M" k
Bone marrow puncture:骨髓穿刺! v* J# x* A$ |
Bone marrow smear:骨髓穿刺涂片
8 U0 k$ j+ Z2 S( H& v0 t4 ZBRM:biological response modifier,生物应答调节剂# e1 L- s  V$ v, `* F1 f6 U
Bu:busulfan,白消安,马利兰 5 J- Q2 h- u. F- C
Buffer:缓冲,缓冲剂,缓冲液* D5 T/ i. [# ~; \: n+ r
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
& {7 G/ L3 k8 \1 @+ P  Z; L% X9 aCAM:cell adhesion molecule,细胞粘附分子5 p4 U8 N( ]3 y2 V
Candida:念珠菌属,假丝酵母属
7 N4 b) g, f1 I' U& @/ oCatheter:导管 " q1 w* x) t. Z1 Q- E/ a3 Z# U+ J
CB:cord blood,脐带血
4 D/ o5 Y/ _7 \4 Z4 J" `CB1348:chlorambucil:苯丁酸氮芥+ Y. q9 B* V+ u8 E
CBC:complete blood count,全血细胞计数
) Y# j! v$ a' o( d/ l4 p  hCBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤6 d0 U$ v) j2 {, h) B7 D  ]
CBSCT:cord blood stem cell transplantation,脐血干细胞移植( T& v$ r7 m! N! c
CCI:corrected count increment,校正增值计数
$ @& J2 F1 [5 H5 a2 g9 bCCNSA:cell cycle non-specific agents,细胞周期非特异性药物 & A1 r# a7 {8 ^& \& A1 Q
CCNU:lomustine,洛莫司汀,环己亚硝脲
5 c7 D& x: G; }7 RCCR:continuous complete remission,持续完全缓解9 u  Z. b3 Y' ~  W1 e
CCSA:cell cycle specific agents,细胞周期特异性药物
* @7 d# ~2 V; b  w3 y! x' @9 jCD:Castleman's disease,Castleman病5 b5 w+ O& e+ m, u& F0 I& ~# x
CD:cluster of differentiation,分化群
4 _; y5 v3 G8 z+ bCD3AK:CD3 activated killer,CD3激活的杀伤细胞- I- j; w. C1 }3 J
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
% k# S, W' U6 P" j9 i; fCEA:carcinoembryonic antigen,癌胚抗原. P4 _0 T0 x9 K2 |, H" r/ c
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病" U: x; j, Y. n7 Q9 Z
Central line:中心静脉导管,见central venous catheter.
8 f# D0 u+ }/ g( h  u1 o1 N: @9 `Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter ( i! `8 j& f/ q
Centrifugation:离心
7 j( J- U4 t0 mCFC:colony-forming cell,克隆形成细胞
) k; Y5 t6 x) M+ ]" b$ _4 r5 TCFU:colony-forming unit,集落形成单位
- @  [- J- f9 q: v  W. I# r& ~/ u+ ~6 rCFU-Blast:colony-forming unit-Blast,原始集落生成细胞
7 _/ U6 L# s0 j* x1 O) k7 _CFU-E:colony-forming unit-erythroid,红系集落生成细胞4 W/ [) {8 c& g5 M- Y9 [! A
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
% g5 {+ J* B( r7 v/ @, i$ BCFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
8 @: |. j" x; `/ P! `7 N  ^8 {CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
: n* c& Q6 H& c* ~8 TCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞; e4 Y, u- V+ e( \' S
CGD:chronic granulomatous disease,慢性肉芽肿病7 i3 |7 ?7 |/ Q* L
CGP:circulating granulocyte pool,循环粒细胞池5 [( D! q0 B$ p9 t$ T
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病
' v1 I& Y' @+ h& L  `6 Z. @8 ]Chemo-responsive:化疗敏感的
9 p1 S" u8 Q& r3 Q1 N9 _Chemotherapy:化学疗法 , X$ J: K% @( k
Chronic慢性的
$ q. Y, K: ~7 {5 SC.I.:continuous infusion,持续静脉点滴
+ w3 R- `5 B4 k. J6 w( NCIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
7 x% V$ _' @' \" U& NCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
" o: Q' [# B! SCLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病6 ^0 X0 Q' A! b; i" B1 u
CML:chronic myelogenous leukemia,慢性粒细胞白血病9 V8 j& a! n) a/ j! L: W. e
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期$ s+ U8 ?7 E7 n7 K' a$ b7 j9 b
CML-BP:CML-blastic phase,慢性粒细胞白血病急变期
6 M) R& L# ^; {' y# Z: cCML-CP:CML-chronic phase,慢性粒细胞白血病慢性期$ q% c) Q. Y0 j, m, M
CMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
: t$ p$ t# n8 W3 C. YCMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
( u1 C/ \% [1 gCMV:cytomegalovirus,巨细胞病毒: K1 q  _* j$ f" S5 j: I" w* i
CNR:cytokine negative response cell,细胞因子不反应细胞; z" |7 E( q9 ^. A6 k- ~
CNS:central nervous system,中枢神经系统
% D" o4 S6 k9 P# M# d: R+ aCNSL:central nervous system leukemia,中枢神经系统白血病
' ]( ]/ c% B, t4 T; A5 oCollection: 采集
, z0 ^4 o1 Z! U: eColony stimulating factor:集落刺激因子 ) l& \6 p' o2 `  K4 q5 @, `
c-onc:cellular oncogene,细胞癌基因
/ f3 ?4 k( N2 K3 N9 V$ y( HConditioning:预处理 - S# L. Q5 i3 L& Q* Q5 G: v
Conjunctivitis:结膜炎# E5 a0 m5 X! R: O: y
Convalescence:恢复,恢复期
: U; |5 r6 J- Y8 l& L3 ICP:cancer procoagulant,癌性促凝物质, ^, k* C* m- o+ |# S1 V
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
8 U9 J4 I' ?# |CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤. b7 U1 V/ O0 m& `$ R; Q' L
Cpmax:peak concentration,峰浓度) j" Z3 [3 }8 n  F8 l5 h4 w0 f- k
CPT:camptothecine,喜树碱
5 [' r& C* O7 g$ y. D/ E4 ZCR:complete remission,完全缓解
) ]; x0 r. p# A" SCRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白7 y+ h) K: [3 _% C! n
CRP:C reaction protein,丙反应蛋白 4 h9 S! r1 [8 a
CRR:complete remission rate,完全缓解率
  }% V9 N$ \+ W" e# E) [Cryopreservation:冷冻保存,深低温保藏 $ u3 r- H$ b) G$ _* _8 k
CSF:colony stimulating factor,集落刺激因子
  _' v3 Q# x8 S' C% Z0 G4 fCSF:cerebrospinal fluid,脑脊液
' a3 K; m: L5 l3 b; TCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤/ C! F$ O, Y7 O% F+ C. z5 Z
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤; X6 x& H% O* A( E0 Q/ v
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
+ ^# b+ o9 @- c! yCyclin:周期素
- S0 N- B# D) }9 w5 ^Cytomegalovirus:巨细胞病毒
- \: S8 f- p  D/ P9 h1 v& s1 [& ]2 PDC:dendric cell,树突细胞5 G- v. P* q4 Y* i0 N' S+ L
D-D:D dimer,D-二聚体  h( U0 ?7 E1 ]$ a! g5 d7 w
Del:deletion,缺失& j! l" c$ K0 m$ p  c
Dermatitis:皮炎 / F/ a. K& c5 l, j" O
De nova AML:非继发性急性髓性白血病
% X% V" f' V: C  r% ^6 X$ G  }DFS:disease free survival,无病生存期0 Q* Z7 t  z' q6 w+ m5 O6 G
DI:DNA index,DNA 指数* w, A' p& }9 @; Q4 T- m3 B7 j
DIC:disseminated intravascular coagulation,播散性血管内凝血6 Q+ s* L) V+ z) W, V+ u, d2 ^
Dilution:稀释1 _) L5 _7 |8 I) K
DL:discordant lymphoma,混杂型淋巴瘤
4 E6 g4 ~7 `; w+ ]6 b7 UDonor:供者% b6 q( C& J  `! R8 @# s
Dysplasia:发育不良,发育异常
+ d$ p, C; U! S" h; j$ }EBV:Epstein-Barr virus,EB病毒# V. D4 c( ?5 a
ECM:extracellular matrix,细胞外基质
7 p! M2 L% g. D) Q; b- O* z-ectomy:(后缀)(外科)切除,除去,去掉 5 U" }  N% m$ f: y/ i3 `
Edema:水肿 3 d  E3 L  v, D
EGF:epithelial growth factor,表皮生长因子* F2 ~' M: s" b1 W+ R+ |
-emia:(后缀)血液疾病
9 b9 d$ ?1 m0 z, WEncephalopathy:脑病
3 Y% C3 s8 B9 h: h( x/ eEncode: 编码
) H, x$ ~; v& oEngraftment:移植物植入 ; Q# s# a, r0 k2 r
Enrich:富集$ V5 T: m% a  Q/ t$ A5 b% Y0 B7 g+ d* X
Enzyme:酶
6 v) q, k9 C4 o( w& H5 XEosinophil:嗜酸性粒细胞
- f" N0 x: K4 ?0 g, P7 {7 PEPO:erythropoietin,促红素,红细胞生成素5 u3 ]  h% M* Y2 L. H
ETT:essential thrombocythemia,原发性血小板增多症. A$ B/ q+ r7 L6 a' o: \
Ex vivo:体外
$ {6 h) C. \3 p% Y1 k! tFACS:fluorescence activated cell sorting,荧光活化细胞分选系统4 F7 j. j( q; y
FCM:flow cytometry,流式细胞分析技术" l, n  c# l& f- w5 S" w6 F5 `! [) w
FDC:follicular dendritic cells,滤泡树突状细胞
$ ]. _$ W; h2 x% \, uFDGF:fibroblast derived growth factor,成纤维细胞源生长因子 . ~# q! b: ]# V# h( v
Febrile:发热的
; G/ M8 m$ ?( J0 PFFP:fresh frozen plasma,新鲜冰冻血浆) [' d, o$ M0 x# {0 b7 I# ~
FGF:fibroblast growth factor,成纤维细胞生长因子
) \+ D& U' t4 h$ u6 L5 v+ F/ [FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
0 x. S1 H' G5 R; n3 v2 QFISH:fluorescence in situ hybridization,荧光原位杂交
" Y" y, C7 c& W6 i" j  H( LFMF:familial Mediteranean fever,家族性地中海热& S# R1 P! n0 Z) w7 y
Foley catheter:弗利氏导尿管,气囊导尿管 * w) U; ~9 y: ^8 Q$ s$ P9 J
FrTBI:fractional total body irradiation,分次全身照射
9 E: G9 x: X8 G0 |FSRC: 胎羊体内增殖的人造血干细胞
6 N3 V- e6 x! q1 H" q. [Fungus:真菌
$ M# ?8 o" L0 Y8 Y9 HFungi: Fungus复数形式' ?6 t; \+ ^7 F, L
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶6 v5 K  F% Q1 x5 e6 G# ?7 B
Gastritis:胃炎 4 N  T$ K: V) F3 K( m6 s( A5 [
Gastrointestinal:胃肠道的
. ?4 ?' k' r7 D: f5 xG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
! h# I6 C) [, v) A" Y. Q7 c5 z  TG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子   w% e& @8 X$ X5 i6 @
GCV:cytomegalovirus,巨细胞病毒8 l! [* a+ N& {4 H& K
GCV:ganciclovir,更昔洛韦3 x) E+ s- o/ {$ ]7 W- m6 ~  ^
GI:gastrointestinal,胃肠道的  J- U! [" x% t. l9 S3 f
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 * M) z7 x1 X3 e) R9 H& T/ x. M
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
, g9 U' C9 f) H8 J2 R- ~Graft rejection:移植排斥(反应) 1 d; d& o" b* C6 T: J
Graft-versus-host disease:移植物抗宿主病
: K' z7 k) u1 I. s1 RGranulocyte:粒细胞
) w7 K! f7 W6 V4 _; a+ _+ kGrowth factor:生长因子 7 m( Z5 M, ?! I1 c3 v# [' O
GTR:granulocyte turnover rate,粒细胞转换率
7 _" r% O4 O! {GVHD:graft-versus-host disease,移植物抗宿主病 9 P0 e: A( E$ k2 m
GVHR: graft-versus-host reaction,移植物抗宿主反应3 c+ [* F0 V/ b, U$ I$ j
GVL:graft-versus-leukemia,移植物抗白血病& f* @4 s/ I) ]  u- E3 {
GVT:graft-versus-tumor,移植物抗肿瘤
+ O" Q8 I) `7 S+ C' K+ RHaploidentical: 半相和的
- |8 j2 Y5 V+ R. v/ `  f7 S# MHarvest: 收集,采集1 ^+ T& p. c3 ~
HC:hemorrhagic cystitis,出血性膀胱炎  B+ P6 c( d0 a2 l
HCL:hairy cell leukemia,毛细胞白血病8 j" o7 b4 b- f4 i( I. N4 v6 f
HD:Hodgkin's disease,霍奇金病' g6 h2 Q5 c; i" X
HD:high dose,大剂量0 g4 x$ n2 H! u( \
Hematocrit:红细胞压积
- |" h3 X9 a+ u! eHematology:血液学 + J7 Y# v& N6 Y- Y4 r9 c' W+ q
Hematopoiesis:造血作用,生血作用' X. @8 x; M& O! B6 ]
Hematopoietic system:造血系统
& X+ E) f" _) O" ZHemoglobin:血色素,血红蛋白 6 R) h7 w5 e0 q: w% B& a, h, g, f
Hemorrhage:出血 0 ?8 }- W" T  J% v: e) y
Hemorrhagic cystitis:出血性膀胱炎
' e$ ], k& a1 y  THepat - :(前缀)肝的
4 C6 b! ?8 x. s4 U) C9 ~Hepatitis:肝炎 6 `0 v" x0 A* E$ a. S6 j& \
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征) _7 w# }- m! o8 I
HGF:hematopoietic growth factor,造血生长因子
4 p1 E- W. \  [7 t. q" {" hHHV:human herpus virus,人疱疹病毒
  w9 C6 ?/ C) f3 ]Hickman catheter:Hichman导管,中心静脉插管
8 F2 t/ q! }7 `% i0 uHIV:human immune deficiency virus,人免疫缺陷病毒
, @6 Q9 s) M; t: g: I4 WHLA:human leukocyte antigen,人类白细胞抗原 ) @2 n; {# C# d  b
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
" ^) k, n# g; [; J' s/ W9 h) d5 wHMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
6 {7 [- ~. O. ~( d8 _& \Homogenic transplantation:同基因移植* U7 C* k  j$ s% I2 Y
Homozygote:纯合子
& r6 @- n6 L  e; U6 n5 Z! A& y! X+ _HPC:hematopoietic progenitor cell,造血祖细胞* b* k2 P. [) w. A2 K: x+ h$ V( w( a
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位% I" r, d1 c1 Y
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病7 {3 E: G/ Z4 e* ]! H! N- Z$ @* y
HSC:Hand-Schuller-Christian disease,韩-薛-柯病7 b. ^! P$ _: Q+ R. Y* U0 a# ]* @" y
HSC:hematopoietic stem cell,造血干细胞
3 D+ D; j1 i- u2 e6 q: iHSR:homogenously staining region,均染色区5 u  b, i- `1 [: f$ G
HSV:herpes simplex virus,单纯疱疹病毒+ w% h" Q) K7 b6 ]& {  z8 i+ r
HTC: typing cell,纯合子分型细胞# M1 I) J7 g4 T
HTLV:human T cell leukemia virus,人类T细胞白血病病毒# Z' K9 @* ?/ N9 [
HVOD:hepatic venous occlusive disease,肝静脉闭塞病
2 e; B& w+ |# C6 JHyper- :(前缀)高,超,(过)多. b( ^* ]- r) N) ]
Hyperalimentation:高营养支持,静脉高营养
* i5 G! `2 I! Y$ J- mHyperpigmentation:色素沉着过度 ' `" g! _2 f* }5 `, {) G
Hypertension:高血压
/ x" u4 W2 q* h. LHypo- :(前缀)(过)低,少于- v! o, G  z' ?. n
Hypotension:低血压
/ L3 I: `5 D" ]7 D( aIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征2 e/ D/ e- p; D2 P( _
id:medium dose,中剂量
) m. J5 ]7 b# i% Tid:initial dose,初始剂量
$ _" [! M4 B: G* r' w7 kIF:involved field,累及野
* d& E% q! j5 r$ ^% c: u5 C! ZIFN:interferon,干扰素
9 i5 `- b! ?$ Y: k& M" nIg:immunoglobulin,免疫球蛋白
. l- j& J# ]" FIGFs: insulin-like growth factor,胰岛素样生长因子- p7 G  J3 `6 o8 }( u
IgH:immunoglobulin heavy chain,免疫球蛋白重链0 l6 E' y& ^$ @6 d1 n
IL:interleukin,白细胞介素
6 U5 e" c9 A7 zIliac crest:髂嵴 . [" e) ^. P; {. u3 n/ b
I.M.:intramuscular,肌肉注射
" z  H1 Y# G  C8 f: x9 D  lImmune system:免疫系统
2 j( D0 I3 Y, K8 K4 I) dImmunocompromised:免疫受损的
7 ?- g) m; o- i7 V% t6 @Immunoglobulin:免疫球蛋白
  r- `" ?) Y% q) l  hImmunological tolerance:免疫耐受
2 v6 i# b! C/ `6 t; eImmunosuppression:免疫抑制 2 B0 Q" L. \/ o2 T; o/ z" I
Incubation:孵育
  J4 ?# K7 J& a# |8 A1 qinformed-consent:知情同意
2 @* C: H. u, \3 L; dIntravenous:静脉内的; `0 r1 e$ p+ Z( j, n' o1 I
inv: inversion,倒位2 l: {$ B% }3 `: [) g
in vitro: 体外,离体
0 l$ _7 l% K# L8 q. [1 i4 |in vivo: 体内
2 I( |- p$ X; w# V2 Y" u6 N8 s5 ?IP:interstitial pneumonia,间质性肺炎9 T! p3 t0 N5 V+ J- f' \4 T
Isolation: 分离
% ~: b' ^7 U) w+ SI.T.:intrathecal injection,鞘内注射
/ K/ q3 i: }% [/ u# _-itis:(后缀)炎症
, T3 X' c) |0 u" k% p( I6 zITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
3 W7 C# `$ Z1 [( [4 f. z- {8 UJaundice:黄疸) J- ^! b8 o  g* y
KPS:Karnofsky score, Karnofsky评分
$ i" V$ {/ r7 Y3 t  ]4 j/ vLAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
8 e* I" c1 m& c* N+ q& g, `6 J0 eLaminar air flow unit:层流间 1 D+ e! d) R2 \1 t1 Y2 G7 v
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
, T) y3 Q# I  GLD:lymphocyte depletion,淋巴细胞消减型
8 }1 n, J0 L( b- p# [LD:low dose,小剂量
( p+ B$ o& m- \! w# WLDH:lactate dehydrogenase,乳酸脱氢酶8 r0 j/ O5 k" d& R7 ^5 I, _
Leukapheresis: 白细胞采集物
& {% ^1 Y% Q$ I, j4 uLeukemia:白血病   W: R. _! N8 Y# F
Leukocyte:白细胞
3 y' Y4 }; u& ~  ]Leukopenia: 白细胞减少症& C* o8 Z$ c. ~' F* l+ j
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原
, Q" |; O$ V7 o/ vLFS:leukemia free survival,无白血病存活期
' M6 V5 J8 T9 aLGL:low grade lymphoma,低度恶性淋巴瘤7 b/ H7 M! c: D6 M3 Y# H; B
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体3 |* d- V- v2 I  B, s8 x
LI:labeling index,标记指数
! H. M, d" Q) P( l: V8 YLIF:leukemia inhibition factor,白血病抑制因子
# p' G4 }, G" E4 Q  lLineage:系
! q3 q" J% I! R1 L. p0 ^" QLOH:loss of heterozygosity,杂合性丢失6 _6 E9 b, N' u
LP:lymphocyte predominance,淋巴细胞为主型" l% M9 d6 c, T% J$ Q
LRP:lung resistance related protein,肺抗性相关蛋白
2 b* E! Q! y' p1 b& \8 ~LTB:life-threatening bleeding,致命性出血2 ^9 Y. e/ b0 j6 w
LTC-IC:long-term culture-initiating cell,长期培养起始细胞0 t8 f& B& y8 b8 W
LTR:long terminal repeat:长末端重复序列
; c/ c, y0 ~& H5 O1 F! }LVL:large volume leukapheresis,大容量白细胞单采
1 A8 S' K7 S; z5 \" Z$ |Lymphocyte: 淋巴细胞
) x$ q% k1 g  k& j& dMacrophage:巨噬细胞' ~: ]0 o% `( _$ B% }
MACS:magnetic activated cell sorting,磁性活化细胞分选  D6 s% I, F7 I8 P9 ?
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
1 e* L( s/ {$ W9 w# ^' \6 s. Z6 TMalabsorption:吸收障碍
( B) B: l* T" y0 yMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
7 y9 w: C( S: k8 b" S$ ?- k7 CMatching:配型9 \* [5 a7 t7 p, k5 @9 p
MBDI:marrow blast decline index骨髓原始细胞减少指数2 G4 F' \3 R" W+ Z
MC:mixed cellularity,混合细胞型$ Q% b; l) H1 ~- e7 V5 ~8 T0 b
McAb:monoclonal antibody,单克隆抗体5 ?0 A$ k$ {: Q  G6 h8 z: J: O
mCR: median complete remission,中位完全缓解
9 q$ F/ H$ n' C0 g; O$ Y4 cMDR:multiple drug resistance,多药耐药
2 I8 {6 M, T' @, SMDS:myelodysplastic syndrome,骨髓增生异常综合征
$ a4 y7 g4 D4 m3 s3 e0 K( QMegakaryocyte:巨核细胞2 n4 G, K1 e( w- T# A! h
Metabolite:代谢物 : E0 ~. y6 P! v: A5 J- \$ V
Metastatic:转移的 " b% E3 H% P( t$ r) ]# n
MF:myelofibrosis,骨髓纤维化" }% J/ O2 ]* G1 K. m1 r
MF:mycosis fungoides,蕈样霉菌病7 S7 m( }9 Y% v3 ~; ~7 w$ I
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
) s( J0 l) E. A' U+ z1 S7 N; w# sMGP:marginal granulocyte pool,边缘粒细胞池
1 R: y9 Y, y7 YMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症7 x+ M( C5 i2 p0 ^% R* N  V3 W
MH:malignant histocytosis,恶性组织细胞增生症
5 W# Q0 `/ `8 x& r( z9 NMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统3 ~6 _9 X. d) K6 D* ~
MHC:major histocompatibility complex,主要组织相容性抗原复合体, t, r% y4 G: M6 N: Q  ]: B# {
MLC:mixed lymphocyte culture,混合淋巴细胞培养 / I4 X" ?% Y1 X4 G% X! r2 j
MLL:mixed lineage leukemia,混合系白血病
- Z# {# J, Y9 R6 IMM:multiple myeloma,多发性骨髓瘤+ z* I' U7 I8 @; v$ q
MNC:mononuclear cells,单个核细胞
4 r$ H! U8 Y. s" _- d5 F% \Mobilization:动员$ P( W* a) G9 b+ t- k
Monoclonal antibody:单克隆抗体
7 x$ f% z8 [# v* k5 @Monocyte:单核细胞
4 b7 E5 q* x% S" ]/ sMonozygotic:单合子的
1 ^* p* }2 D7 y9 d( U: i% RMorbidity:发病率 ! `0 n# r. K5 \, I3 E+ v- f
MPD:myeloproliferative disease, 骨髓增殖性疾病, Y3 `% k- r6 t$ k% L6 y3 b
MPO:myeloperoxidase,髓过氧化物酶2 l" V* x$ z% m; {% ^4 B* l
MRD:minimal residual disease,微小残留病变 ! v/ f- C  C" I
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
7 z. X& h9 k" Y" r$ {Mucositis:粘膜炎 . d5 L# G$ h) P  ?5 S
MUD:matched unrelated donor,非血缘关系配型相合供体/ F& Y, v0 T2 C
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
1 F1 r  `, b; j- {0 m# vNB:neuroblastoma,神经母细胞瘤
) n+ ?/ Y/ |( T- BNBM:normal bone marrow,正常骨髓, m" C* D) h' ^
Negative selection:阴性选择
! ]8 ^" @! }% ]  A& dNeuro- :(前缀)神经的; ~7 Q6 t. J7 f/ ~: a1 S# Z7 H
Neutropenia:中性粒细胞减少症 7 ^, x3 x: s2 _9 r$ `- p/ V
Neutrophil:中性粒细胞
7 p: B& @' d/ M+ h+ YNG:neutrophil granulocyte,中性粒细胞
, c4 l6 j* S3 |. Z* o/ R. xNGF:nerve growth factor, 神经生长因子8 C; X! I* T+ M
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤. a3 {; c9 b4 C' F* E7 a
NK: nature killer cell,自然杀伤细胞
1 b( [8 [5 |8 X. t- ~4 uNonmyeloablative transplantation: 非清髓性移植
& J" s% g' `1 Q' RNPO:不能进食
8 ]# ^1 w' a: Y0 x, g4 \9 x3 c, d0 {* `NS:nodular sclerosis,结节硬化型
8 `# I" Q* Y$ ?8 e1 f. n% {$ EOncology:肿瘤学 8 r8 O& L8 B. w% i' b# y
Oto- :(前缀)耳的( H3 @5 K6 }4 e
PA:plasminogen activator,纤溶酶原激活物7 G: q  }) G1 W% Z- L
Packed red blood cells: 压积红细胞
7 U) }! {3 ~" r* D9 o* k' wPAE:post antibiotic effects,抗生素后续作用
6 {) ~4 j: g, M" v* F6 PPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
; H; l' S4 \. D5 `+ bPalliative:减轻的,缓解的
  p" c( P' `/ n, y9 tpalliative care unit (PCU):终末期病房,临终关怀病房
& k& x+ d& q6 k. Y. P% _$ r+ tPancytopenia:全血细胞减少症
* y* |1 a5 r$ V+ U; p* _-pathy:(后缀)病 ! s' M* p, y. R  J, s& v9 a
PB:peripheral blood, 外周血# _. J, T4 e( B& X1 ^
PBL:peripheral blood lymphocyte,外周血淋巴细胞
+ C; u9 Z5 x  x' f) U  j4 HPBPC:peripheral blood progenitor cell,外周血祖细胞
; E- Q" N+ b) V, i" lPBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
! y- t) t9 V5 a2 z4 @# L5 u% O; TPCA:procoagulant activity,促凝活性物质
; R0 A/ n4 l% t/ f3 s4 v; JPCD:programmed cell death,细胞程序化死亡
! D" K; b; f: s. A( I+ J- q' MPCL:plasma cell leukemia,浆细胞白血病
7 ?9 ?/ G8 y- A4 |7 dPCLI:plasma cell label index,浆细胞标记指数
" P# n. X- O; I1 p+ G2 Q2 r  R8 xPCR:polymerase chain reaction, 多聚酶链反应1 G( j% z' ^* N# [5 ^2 ?0 Z
PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
( ^) V9 }) N3 Q# ^. r# gPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
$ g7 [6 I! J& t% PPDD:percentage depth dosage,百分深度剂量
- t/ y& |6 p/ o4 J+ z4 ~1 z! u3 i) s" ~PDGF:platelet derived growth factor,血小板衍生生长因子8 ~8 q% x7 `8 f, V/ y: O* g' j: V
PDR:primary drug resistance,原药耐药) s/ d+ P/ R9 F) \# r; O. a
PE:plasma exchange,血浆置换
5 B" N4 @% f3 w& \: }-penia:(后缀)缺乏,不足
% W; Y* E$ u4 _6 Y5 Q; o/ T0 |Peripheral neuropathy:周围神经病变 4 K$ L; G! I3 ~3 T
Petechiae:瘀点,瘀斑 - _  z. m5 e1 F' Q
Pfu: plaque forming unit,空斑形成单位
( }# D4 _; C' E) P1 s2 CPHA:phytahematoagglutinin,植物血凝素
( F+ U' R1 ^/ {* hPhlebitis:静脉炎 ' p0 o" G  f3 R+ _+ s
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
/ W  N# X& c. R" g, `-plasia:(后缀)发展,形成 - w" t0 L; `7 p, y0 ~6 {! M2 m
Plasma:血浆% v% L3 I2 V+ [* B( D' ^8 q6 P
Plasma cell: 浆细胞 ( r. ]8 f6 D! M3 w2 B
Platelet:血小板
+ C( @3 u2 [9 O4 q  hPLG:plasminogen,纤溶酶原
/ i9 I3 f  D6 L/ N; m1 Q  kPLL:prolymphocytic leukemia,幼淋巴细胞白血病
1 s: j: X' n/ `; P; h' ePLT:platelet,血小板- b. Z6 S9 ?3 M9 _
PLT:primed lymphocyte test,预致敏淋巴细胞试验
" l5 r4 ?5 Q# k) R; }- GPMN:polymorphonuclear leukocyte,多形核白细胞; n! v5 [+ H3 s( \$ D$ c9 E8 u. ?( T1 G
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷, s3 G4 t/ c% {! n& B
PNRE:p53 negative response element,p53阴性反应元件7 O  V9 j% ]& `
POD:PML oncogenic domain,PML癌基因结构域
/ _: |, Z1 C: X( ]$ OPolycythemia:红细胞增多症
3 D/ \$ y. j/ F' P& }1 s) XPositive selection:阳性选择
8 H5 {& [4 X+ K2 O: gPPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
* |& d& F5 G- ?1 ]( q: QPreparative regimen:预处理方案
: L- i* \# g' a  K% z% dProgenitor:前体,祖先
+ B5 P% i7 Q# e" }" w9 B, p6 Z" xPrognosis:预后 ! i2 ?; u4 p' D1 c: d
Prophylactic:adj.预防的;n. 预防性,预防药+ u, ~! B9 I5 }* x% c# S* q  v
Prophylaxis:预防法,预防+ B! ?+ ?6 b0 g; H  e1 d2 m
Protocol:草案,协议,治疗方案
6 A) h) K7 O  J- KProto-onc: proto-oncogene,原癌基因
7 a" |# x# ^  c" R% YPSS:posterior superior spine,髂后上棘& k; _4 f+ e% ]; K1 `0 p
PT:prothrombin time,凝血酶原时间7 U; [0 E, F2 W
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤$ l. P  f* @  O
PTH:post-transfusion hepatitis, 输血后肝炎
' l: w9 D4 e' @- F  {Pulmonary:肺的
+ n( P0 S# _4 {- T5 k  C: N, `Purging:净化$ b/ j- a; T* c7 d1 L/ K/ o
Purity:纯度+ D: u$ g* z/ Z- I. r$ m7 A
PV:polycythemia vera,真性红细胞增多症% Q8 \0 a& c4 d5 Z! r
Quality of Life (QOL):生活质量
+ g+ a8 y6 G& `1 r. D( DRA:refractory anemia,难治性贫血
0 x" c, I0 E- K. L, HRAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
  ?* K& A+ i# @$ C7 S0 @5 K$ \4 _RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型/ o* j& S) K/ A5 u7 ]" b7 }7 {
RAR:retinoic acid receptor,维甲酸受体
+ Y$ D" r9 P" sRAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多$ S9 h4 z2 o, s' \$ g* j- }2 u# u. A
RAS:retinoic acid syndrome,维甲酸综合征
* d3 E& i9 W& r$ O2 lRB:retinoblastoma,视网膜母细胞瘤! G, i0 X' W4 M0 U- f4 D3 J9 i
RBC: red blood cell,红细胞 9 ~  L  V4 W; f) _1 k1 Z& _9 z
Reagent:试剂
6 _2 I8 O3 ?( a$ U! cRecipient:受者 ! a3 F# o: n  K8 ~! L
Rejection:排斥
. F7 g& {  ]9 d6 MRelapse:复发
# @& V9 }7 C* v# I' GRemission:缓解
: V( z7 y! F6 L; wRenal:肾脏的,肾的 . s, F6 N& U5 w, `9 A5 K
RFS:replase free survival,无复发生存$ P. ?5 W% v$ P& G
RPC:radiation protective competence, 辐射保护能力
) ]) D- I  I9 x4 v, ]. G$ i( BRegimen-related toxicity (RRT):预处理相关毒性0 w  D0 l/ e* f6 _4 @
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
# ^9 [4 o1 L! T  [- oSBB:sudan black B,苏丹黑B
4 X, V# p$ [& e$ ZSCE:sister chromatial exchange,姐妹染色单体交换/ N/ J' A0 Q5 N
SCF:stem cell factor,干细胞因子
% U1 k6 y/ q, C$ `( XSCid:severe combined immunodeficiency disease,重症联合免疫缺陷
: j8 `8 M  z; T1 @5 k' N6 USCL:stem cell leukemia,干细胞白血病: B' T1 h( O# a3 p
SE:specific estarase,特异性酯酶
  u! S8 [/ a# M' v4 WSelectin:选择素
, [. |4 q5 A: D; }% rSense primer:同义引物
7 t9 h- i2 @" o; USeparation:(细胞)分选3 N3 W! \$ J( _2 {4 E# n% k
Sepsis:脓血病,败血病 ) g0 G# ]( x/ P* |4 B
Sequencing测序
! E9 K1 @3 G- ^; c. gSF:serum ferritin,血清铁蛋白, O4 W5 b' e! y2 P1 ?+ H; G4 H
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大
, \6 l2 J7 m' J% H, G& k0 tSIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法( c( [6 ^8 X" y0 L# m# c
SLE:systemic lupus erythematosus,系统性红斑狼疮4 m$ T7 _. Q  U  y5 H4 O2 a3 b4 m
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
& i; L% }% O4 x2 [& D) C. }Solid tumor:实体瘤0 y7 D" O1 g2 r4 }8 P7 U0 b0 D
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
7 g  l/ V  }/ v: b4 |SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞0 u% {/ |0 u2 y' o2 V! c
SS:Sezary syndrome,Sezary综合征
+ {$ u& o. B7 d$ k& j. M' V2 BStem cell:干细胞
3 K+ N, B' C8 u2 M* NSTNI:subtotal nodal irradiation,次全淋巴结照射 ) S" n) s" P$ s5 T& J
Stomatitis:口炎 : Q  q+ ~3 }" {$ c
Subclavian catheter:锁骨下导管
2 r; t- L* L5 p  ~Supernatant:上清$ h; y$ |, d, a
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
, J: o2 o7 L* y4 d7 }$ ESyngeneic:同基因的& r  W, o  [; N
TAM:tumor associated macrophage,肿瘤相关巨噬细胞+ M# T2 Q9 p" ]! Q/ C0 x7 q, c. C! }  n
t-AML:treatment associated AML,治疗相关的急性髓性白血病/ a* s; [/ t6 w& z1 V; b
TA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病% Q! I8 B5 s4 M% Y1 ?" p! z
TAA:tumor associated antigen,肿瘤相关抗原9 X; D/ i! z, M" a
TBGP:total blood granulocyte pool,总血液粒细胞池2 z, w2 s9 @, ~4 U) I0 U1 i% ]
TBI:total body irradiation,全身照射
% |4 i* P: D1 y- vTc:time of cell cycle, 细胞周期时间
3 @1 c- U' {- U4 h$ uTCD:T cell depletion, T细胞去除
8 _* Y5 A+ r( J' c% E: R# J  i3 KTCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 ' [8 p8 g+ q6 t' Z; s" C2 v3 j
TCR:T cell receptor,T细胞受体$ \( ?0 F' C) G# B% N, v( G
TCS:tumor cell survival,肿瘤细胞成活
6 s8 \" V* R  a/ Z/ d9 yTEN:total enteral nutrition,完全胃肠内营养( X, |+ c* h$ H+ g: B- K9 s
TF:tissue factor,组织因子/ T+ {9 z$ p' t/ i" |# m/ ]- a
TF:thymic factor,胸腺因子( T2 y& z8 Q& @1 Q) a
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物- ~  O. X0 U) U. L+ h
TGF:therapeutic gain factor,治疗获得系数& w" i) T6 _' T8 u
TGF-β:transforming growth factor-β,转化生长因子β/ t4 c5 G3 f- ?* i5 Z, y$ W" E6 [7 t
Thrombocyte:血小板
8 p* R: ~5 _8 t( `" ]9 q" bThrombocytopenia:血小板减少症$ ^5 v4 u3 a1 o4 i
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
6 P# i$ M1 o& a6 r1 @5 {0 ITL:testis leukemia睾丸白血病
& d1 z+ x& t7 V5 Z$ c7 k4 N- h# d2 S$ cTLI:total Lymphoid irradiation,全淋巴照射% l' X" B8 e; j: X# [! T3 q6 q
Thrombotic microangiopathy (TMA):血栓性微血管病
% y& w5 S: k( ~1 ?! s, lTNF:tumor necrosis factor,肿瘤坏死因子
6 m% N+ b- e  r5 M. j1 s* J: e$ b; }TNI:total nodal irradiation,全淋巴结照射
3 m0 n, N6 M5 w5 e& X0 ?- Q, `TOPO II:topoisomerase II,拓扑易构酶II
7 a7 Y5 J; E9 T% f  YToxin:毒素 + r) m0 ^. X2 K" n: Y
Tpdt:potential doubling time,倍增时间$ t+ r6 R: A; B( T3 o* G, R6 K3 g6 t
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病' Y, k; u/ H- v( o  E2 c5 i
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
1 N* X9 }9 p- F4 o3 B! T* iTPO:thrombopoietin,促血小板生成素" G5 @* i1 t5 b' R8 @9 j" }
TPS:treatment planning system,治疗计划系统
2 g3 F" }: m4 T9 o7 m' yTranslocation:易位* ~# m; d* H. j2 G
Trauma:创伤 * ]5 E2 z6 O- D1 W6 M
TRM:transplantation related mortality,移植相关死亡率
: |! J& j- d0 r3 d/ L6 }. LTSC:timed-sequential chemotherapy,时相序贯化疗
& [% E4 t/ P! @, cTSPA:triophosphoramide,噻替派) t! I! n) O- y
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
0 M7 u- B9 H5 cTumor:肿瘤
' ^: p; B: P" w2 W& BTumor burden:肿瘤负荷 * ?1 x& x1 D! i4 i0 f. J) |- v
UCB:umbilical cord blood,脐带血* v1 E$ o1 S4 n6 X9 j7 z! W0 [
Ultrasound:超声 5 T- l: \; W6 ?  F# }) v  c
Umbilical cord:脐带
) P, M9 H6 {/ u7 P; d7 gVAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
) X  R/ B6 {! j, jVGPR:very good partial remission,非常良好的部分缓解
! I. B; {' o& `/ OViability:活性) l: ^7 P, ?- Y
Virus:病毒 $ ^$ H' |4 ]# |( H0 @
VOD:veno-occlusive disease,静脉阻塞性疾病
# ~  q% K4 h+ [! V( e5 kv-onc: virus oncogene,病毒癌基因
5 p1 |5 q; _( ?+ I4 RVPF: vascular permeability factor,血管渗透因子! M& ~- a+ A1 E: I5 T% g  S$ D
VZV:varicella zoster virus,水痘带状疱疹病毒
8 g* f( N4 f7 [0 f  C* K) AWBC:white blood cell,白细胞
7 T: k6 w5 @, M$ f4 U; u( BWhole blood:全血
, A' ~, F; d" I( O* s( OWT:Wilms tumor,肾母细胞瘤
, I  q0 h6 x; N9 G- g' V* KXerostomia:口腔干燥症
: c( y5 Z2 u+ HYield:产量
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-2-20 09:42

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.